Financial Planning Analysis At Agios Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Financial planning analysis at agios pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Financial Planning Analysis At Agios Pharmaceuticals Today - Breaking & Trending Today

Affinivax Appoints Elizabeth Radcliffe as Chief Financial Officer


Published: May 05, 2021
 
 
CAMBRIDGE, Mass. (BUSINESS WIRE) Affinivax, Inc. (“Affinivax”), a clinical stage biopharmaceutical company pioneering the development of a novel class of vaccines with its MAPS™ (Multiple Antigen Presenting System) platform, today announced that Elizabeth Radcliffe has joined the company as Chief Financial Officer. She is a strategic business leader with deep experience managing finance and planning across the full range of biopharmaceutical R&D, commercial and business operations, including leadership roles at Arrakis Therapeutics, Agios Pharmaceuticals, and Biogen. Ms. Radcliffe joins Affinivax at a pivotal time as the company evolves its vaccine pipeline and expands its operations. ....

United States , United Kingdom , Harvard University , Steven Brugger , Elizabeth Radcliffe , Yale University , Excelon Corporation , Parthenon Group , Agios Pharmaceuticals , Melinda Gates Foundation , Affinivax Inc , Financial Planning Analysis At Agios Pharmaceuticals , Sloan School Of Management , Business Development , Multiple Antigen Presenting System , Chief Financial , Arrakis Therapeutics , Liz Radcliffe , Business Wire , Chief Executive Officer , Vice President , Financial Planning , Senior Director , Medical Affairs , Multiple Sclerosis , Portfolio Management ,